Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
Immatics US, Inc.
National Institutes of Health Clinical Center (CC)
Biocon Limited
Pfizer
Maastricht University Medical Center
Pfizer
Almirall, S.A.
Immorna Biotherapeutics, Inc.
The Christie NHS Foundation Trust
Dragonfly Therapeutics